Skip to main content

Peer Review reports

From: Influenza vaccination should have no border: cost-effectiveness of cross-border subsidy

Original Submission
23 Jul 2020 Submitted Original manuscript
10 Aug 2020 Author responded Author comments - Dan Yamin
Resubmission - Version 2
10 Aug 2020 Submitted Manuscript version 2
30 Aug 2020 Author responded Author comments - Dan Yamin
Resubmission - Version 3
30 Aug 2020 Submitted Manuscript version 3
8 Oct 2020 Reviewed Reviewer Report
3 Nov 2020 Reviewed Reviewer Report
23 Dec 2020 Author responded Author comments - Dan Yamin
Resubmission - Version 4
23 Dec 2020 Submitted Manuscript version 4
5 Jan 2021 Reviewed Reviewer Report
7 Jun 2021 Reviewed Reviewer Report
15 Jun 2021 Author responded Author comments - Dan Yamin
Resubmission - Version 5
15 Jun 2021 Submitted Manuscript version 5
25 Jun 2021 Reviewed Reviewer Report
12 Jul 2021 Author responded Author comments - Dan Yamin
Resubmission - Version 6
12 Jul 2021 Submitted Manuscript version 6
3 Aug 2021 Author responded Author comments - Dan Yamin
Resubmission - Version 7
3 Aug 2021 Submitted Manuscript version 7
4 Aug 2021 Author responded Author comments - Dan Yamin
Resubmission - Version 8
4 Aug 2021 Submitted Manuscript version 8
Publishing
5 Aug 2021 Editorially accepted
12 Aug 2021 Article published 10.1186/s12889-021-11601-2

You can find further information about peer review here.

Back to article page